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Abstract
The risk of type 2 diabetes is approximately 2-fold higher in African Americans than in European Americans even after
adjusting for known environmental risk factors, including socioeconomic status (SES), suggesting that genetic factors may
explain some of this population difference in disease risk. However, relatively few genetic studies have examined this
hypothesis in a large sample of African Americans with and without diabetes. Therefore, we performed an admixture
analysis using 2,189 ancestry-informative markers in 7,021 African Americans (2,373 with type 2 diabetes and 4,648 without)
from the Atherosclerosis Risk in Communities Study, the Jackson Heart Study, and the Multiethnic Cohort to 1) determine
the association of type 2 diabetes and its related quantitative traits with African ancestry controlling for measures of SES and
2) identify genetic loci for type 2 diabetes through a genome-wide admixture mapping scan. The median percentage of
African ancestry of diabetic participants was slightly greater than that of non-diabetic participants (study-adjusted
difference=1.6%, P,0.001). The odds ratio for diabetes comparing participants in the highest vs. lowest tertile of African
ancestry was 1.33 (95% confidence interval 1.13–1.55), after adjustment for age, sex, study, body mass index (BMI), and SES.
Admixture scans identified two potential loci for diabetes at 12p13.31 (LOD=4.0) and 13q14.3 (Z score=4.5, P=6.6610
26).
In conclusion, genetic ancestry has a significant association with type 2 diabetes above and beyond its association with non-
genetic risk factors for type 2 diabetes in African Americans, but no single gene with a major effect is sufficient to explain a
large portion of the observed population difference in risk of diabetes. There undoubtedly is a complex interplay among
specific genetic loci and non-genetic factors, which may both be associated with overall admixture, leading to the observed
ethnic differences in diabetes risk.
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Approximately 13% of the U.S. adults have type 2 diabetes [1],
representing a significant burden on public health in the United
States. Type 2 diabetes is approximately twice as prevalent in
African Americans as in European Americans. In the Multiethnic
Cohort (MEC), this racial/ethnic difference persisted after stratifi-
cation by body mass index (BMI) [2]. Data from the National
Health and Nutrition Examination Survey (NHANES) confirm the
substantial racial disparity in diabetes across the U.S. [1,3]. In the
Atherosclerosis Risk in Communities (ARIC) Study, African
Americans are twice as likely as whites to develop incident type 2
diabetes—a disparity which persists even after extensive adjustment
for socioeconomic status (SES) and behavioral risk factors [4]. This
persistent disparity suggests that genetic factors may contribute to
ethnic differences in susceptibility to type 2 diabetes.
Despite remarkable efforts in the past three years that have led
to the discovery of more than 30 susceptibility loci for type 2
diabetes and related quantitative traits [5–18], there has been only
one genome-wide association study of type 2 diabetes in African
Americans [19]. The disparity in diabetes prevalence between
Americans of African and European ancestry makes diabetes an
attractive phenotype to study by admixture mapping, a method
that systematically scans the genomes of groups of recently
admixed individuals (e.g., African Americans) to search for genetic
loci where persons with a disease or trait, in aggregate, have more
(or less) African ancestry than their genome-wide average.
Admixture mapping and subsequent fine-mapping studies have
been successful in identifying genetic variants for other complex
phenotypes, including prostate cancer [20,21], end stage renal
disease [22], white blood cell count [23,24], and circulating levels
of interleukin 6 soluble receptor [25].
Given the observed ethnic/racial disparities in diabetes
prevalence, we hypothesized that some diabetes susceptibility
alleles are present at higher frequency in African Americans than
in European Americans, resulting in association between genetic
ancestry and diabetes risk that is independent of its association
with other non-genetic risk factors for type 2 diabetes. Thus we
sought 1) to establish the association of genetic ancestry with
diabetes and related quantitative traits in African Americans, after
accounting for the non-genetic risk factors, and 2) to identify
diabetes susceptibility loci by conducting a genome-wide admix-
ture mapping scan. To maximize power to detect genetic
association, we performed a pooled analysis of 7,021 African-
American participants, including 2,373 diabetic cases, from three
U.S. population cohorts, including the ARIC Study, the Jackson
Heart Study (JHS), and the MEC study.
Results
Characteristics of participants
The characteristics and genetic ancestry of the 7,021 African
Americans (including 2,373 with type 2 diabetes) included in the
study are shown in Table 1 and Figure S1. The overall median
global African ancestry was 83.7% (interquartile range, 76.2%–
88.7%). African ancestry distributions were different among the
three cohorts, with MEC participants having a lower average
percentage of African ancestry (P,0.001). Diabetic participants
tended to have higher BMI, lower education level and lower
family income, compared to non-diabetic participants (Table S1).
Association of ancestry with diabetes
Pooling the three cohorts together, the median percentage of
African ancestry of diabetic participants was 1.6% greater than that
of non-diabetic participants (P,0.001, adjusted for study). The odd
ratios (ORs) for diabetes were higher with increasing tertiles of
African ancestry (P for trend,0.001, Model 1 in Table 2) after
adjustment for age, sex, and study. With additional adjustment for
Table 1. Genetic African ancestry by participant characteristics and study.
ARIC JHS MEC
Characteristic No. (%)
African Ancestry,
Median (IQR), % P Value
a No. (%)
African Ancestry,
Median (IQR), % P Value
a No. (%)
African Ancestry,
Median (IQR), % P Value
a
Overall 2285 (100) 84.9 (77.8–89.5) 3185 (100) 84.0 (77.9–88.7) 1551 (100) 80.6 (69.8–87.4)
Age, y
21–39 0 (0) 237 (7.4) 84.1 (79.4–87.9) 0 (0)
40–59 1741 (76.2) 85.0 (78.2–89.4) 0.872 1519 (47.7) 83.9 (77.9–88.3) 0.455 627 (40.4) 82.0 (72.4–87.9) ,0.001
$60 544 (23.8) 84.6 (76.4–89.9) 1429 (44.9) 84.2 (77.4–89.2) 924 (59.6) 79.3 (67.5–86.9)
Gender
Men 918 (40.2) 85.1 (78.5–89.6) 0.187 1210 (38.0) 83.8 (77.6–88.2) 0.100 1001 (64.5) 79.2 (67.5–86.7) ,0.001
Women 1367 (59.8) 84.7 (77.4–89.3) 1975 (62.0) 84.2 (78.2–88.8) 550 (35.5) 82.2 (73.7–88.3)
BMI, kg/m
2
,25 530 (23.2) 83.9 (76.8–89.0) 403 (12.6) 84.0 (78.2–88.8) 277 (17.8) 78.9 (67.9–85.8)
25–,30 865 (37.9) 84.1 (76.8–89.2) ,0.001 1053 (33.1) 83.8 (77.0–88.5) 0.286 682 (44.0) 79.2 (67.2–87.2) ,0.001
$30 890 (38.9) 85.9 (79.1–89.9) 1729 (54.3) 84.3 (78.3–88.7) 592 (38.2) 82.1 (73.4–88.3)
Diabetes
Yes 631 (27.6) 85.7 (79.3–89.5) 0.008 829 (26.0) 85.3 (79.5–89.3) ,0.001 913 (58.9) 81.3 (71.8–88.1) ,0.001
No 1654 (72.4) 84.6 (77.0–89.4) 2356 (74.0) 83.6 (77.3–88.3) 638 (41.1) 79.4 (66.2–86.1)
ARIC, the Atherosclerosis Risk in Communities Study; JHS, the Jackson Heart Study; MEC, the Multiethnic Cohort; IQR, interquartile range; BMI, body mass index
(calculated as weight in kilograms divided by height in meters squared).
aP value was generated from the Wilcoxon rank-sum test or the Kruskal-Wallis test.
doi:10.1371/journal.pone.0032840.t001
African Ancestry and Diabetes
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e32840BMI, individuals in the second and third tertiles were still,
respectively, 1.21 and 1.4 times more likely to have diabetes than
their counterparts in the first tertile (Model 2 in Table 2).
To determine whether the observed excess odds of diabetes with
increasing African ancestry might further be explained through the
association between genetic ancestry and other non-genetic risk
factors, such as measures of SES, we constructed additional
models using only ARIC and JHS, where these data were
available. Univariately, measures of SES were associated with both
genetic ancestry (Table S2) and diabetes (Table S3). Even after
adjusting for the three SES indicators, individuals in the second
and third tertiles of African ancestry were about 1.27 and 1.37
times more likely to have diabetes than those in the first tertile
(Model 3 in Table 2). The three SES indicators together accounted
for about 22% of the excess odds of diabetes with increasing
African ancestry. Collectively, BMI and the three SES measures
explained about 30% of the excess odds of diabetes observed in
individuals in the third tertile. The associations between increasing
African ancestry and greater odds of diabetes were also evident in
models based on restricted cubic splines (Figure 1).
Association of ancestry with diabetes-related traits
In ARIC and JHS only, we assessed the association of African
ancestry to hemoglobin A1c (HbA1c), fasting glucose and insulin
level, and insulin resistance, which was estimated by the
homeostasis model assessment (HOMA-IR) (Table S4 and Table
S5). A total of 4,880 participants had measurements on HbA1c,
and 5,037 had fasting glucose and insulin level. Greater African
ancestry was significantly correlated with higher HbA1c (P,0.001,
see also Figure S2). However, African ancestry accounts for only
0.7% of the variance in HbA1c levels after adjustment for age, sex
and study, while SES alone accounted for a slightly higher
proportion of variance of 1.1%. After excluding individuals who
were receiving diabetes treatment (because such treatment directly
affects trait levels), the effects of ancestry generally became weaker
(Table 3). The other three traits, fasting glucose, insulin and
HOMA-IR levels, were also positively associated with African
Table 2. Odds ratio of diabetes by genetic African ancestry.
African Ancestry Excess Odds Explained, %
a
Study and Model Tertile 1 Tertile 2 Tertile 3 P Value for Trend Tertile 2 Tertile 3
ARIC, JHS and MEC combined
African ancestry, % ,79.4 79.4–87.2 .87.2
Diabetes, yes/no, No. 774/1574 763/1612 836/1462
Model 1, base
b 1 [Reference] 1.25 (1.10–1.43)
f 1.48 (1.29–1.69)
g ,0.001 [Reference] [Reference]
Model 2, BMI
c 1 [Reference] 1.21 (1.06–1.39)
f 1.40 (1.22–1.61)
g ,0.001 16.0 16.7
ARIC and JHS combined
African ancestry, % ,80.5 80.5–87.5 .87.5
Diabetes, yes/no, No. 296/1088 255/1000 406/962
Model 1, base
b 1 [Reference] 1.35 (1.16–1.57)
g 1.47 (1.26–1.71)
g ,0.001 [Reference] [Reference]
Model 2, BMI
c 1 [Reference] 1.32 (1.17–1.70)
f 1.40 (1.20–1.64)
g ,0.001 8.6 14.9
Model 3, SES
d 1 [Reference] 1.27 (1.09–1.49)
f 1.37 (1.17–1.59)
g ,0.001 22.9 21.3
Model 4, BMI+SES
e 1 [Reference] 1.26 (1.07–1.48)
f 1.33 (1.13–1.55)
g ,0.001 25.7 29.8
ARIC, the Atherosclerosis Risk in Communities Study; JHS, the Jackson Heart Study; MEC, the Multiethnic Cohort; BMI, body mass index (calculated as weight in
kilograms divided by height in meters squared); SES, socioeconomic status (including education, income and occupation).
aExcess risk explained is defined as (h12h2)/(h121) where h1 is the odds ratio of diabetes due to increase in African ancestry in Model 1; h2 is the odds ratio after
additional adjustment for covariates in each model; and h121 is the excess odds of diabetes due to increase in African ancestry.
bModel 1: odds ratio (95% confidence interval) is adjusted for age, sex, and study.
cModel 2: odds ratio (95% confidence interval) is adjusted for covariates in Model 1 and BMI.
dModel 3: odds ratio (95% confidence interval) is adjusted for covariates in Model 1 and SES.
eModel 4: odds ratio (95% confidence interval) is adjusted for covariates in Model 1, BMI, and SES.
fP,0.05, as compared to the reference tertile.
gP,0.001, as compared to the reference tertile.
doi:10.1371/journal.pone.0032840.t002
Figure 1. Odds ratio of type 2 diabetes by African ancestry in
the ARIC and JHS studies. Odds ratios were based on restricted
cubic splines with knots at the 5th, 35th, 65th and 95th percentiles. The
reference was set at the 5th percentile (63.8%) of the African ancestry
distribution. The odds ratio was adjusted for age, sex and study (shot-
dashed line), and further adjusted for socioeconomic status, including
education level, family income, and occupations (long-dashed line). The
solid line indicates the odds ratio adjusted for age, sex, study,
socioeconomic status, and BMI; the shaded area represents its 95%
confidence intervals.
doi:10.1371/journal.pone.0032840.g001
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statistically significant (Table 3 and Table S5).
Admixture scans
We conducted genome-wide admixture scans on type 2 diabetes
in the 7,021 African Americans (Figure 2 and Table S6). In the
diabetic cases, we detected an admixture association in diabetic
cases at 12p13.31 with a locus-specific LOD of 4.0, just reaching
the threshold for suggestiveness. The 12p13.31 peak was also
supported by a case-control Z score of 24.2 (nominal P=
3.3610
25), which was marginally genome-wide significant. At this
locus, diabetic cases had lower European ancestry (i.e., higher
African ancestry) than non-diabetic controls. The second strongest
admixture signal was observed nearby at 12q13.13 (locus-specific
LOD=3.8), and the third was at 1p33 (locus-specific LOD=3.5).
There were no other loci with LOD scores .2.5. Averaging the
LOD scores across all loci in the genome, we obtained a genome-
wide score of 1.5, again reaching the threshold of 1 for
suggestiveness. Interestingly, at 13q14.3 the LOD scores was far
from significant (locus-specific LOD=1.1), but this locus had both
the largest magnitude (either positive or negative) case-control
statistic anywhere in the genome (Z score=4.5, nominal
P=6.6610
26), exceeding the level of nominal genome-wide
significance. At the 13q14.3 locus, the diabetic cases had higher
European ancestry than the non-diabetic controls.
Discussion
We have conducted a large-scale admixture genetic analysis in
more than 7,000 African Americans to determine the association
of African ancestry with type 2 diabetes and to map susceptibility
loci for type 2 diabetes. With 2,373 cases with type 2 diabetes and
4,648 controls, we found that greater African ancestry was
significantly associated with type 2 diabetes and HbA1c values even
after adjustment for BMI and markers of SES, including
education, income, and occupation. Despite the significant
association between greater African ancestry and type 2 diabetes,
no major locus for diabetes could be detected by our admixture
scans, using the more powerful locus-genome statistic.
Our results show that there is 30% to 40% increase in odds of
type 2 diabetes among participants in the highest (.87.5%) vs. the
lowest (,80.5%) tertile of African ancestry, even after adjustment
for measures of SES and/or BMI. Our restricted cubic spline
models also support this extrapolation, implying that genetic
ancestry is a major independent determinant of the observed
Table 3. Mean difference in the levels of diabetes-related quantitative traits by genetic African ancestry after excluding
participants receiving diabetes treatment.
Trait and Model African Ancestry
a
P Value for Trend Effect Explained, %
b
Tertile 1 Tertile 2 Tertile 3 Tertile 2 Tertile 3
Hemoglobin A1c, % (n=4100)
Model 1, base
c 0 [Reference] 0.10 (0.02–0.18)
g 0.10 (0.02–0.18)
g 0.011 [Reference] [Reference]
Model 2, BMI
d 0 [Reference] 0.08 (0.01–0.16)
g 0.09 (0.01–0.17)
g 0.028 20.0 10.0
Model 3, SES
e 0 [Reference] 0.07 (20.01–0.16) 0.07 (20.01–0.16) 0.073 30.0 30.0
Model 4, BMI+SES
f 0 [Reference] 0.06 (20.01–0.14) 0.06 (20.02–0.14) 0.122 40.0 40.0
Glucose, mg/dL (n=4423)
Model 1, base
c 0 [Reference] 1.20 (20.89–3.28) 1.57 (20.51–3.65) 0.139 [Reference] [Reference]
Model 2, BMI
d 0 [Reference] 0.93 (21.14–2.99) 1.16 (20.91–3.22) 0.272 22.5 26.1
Model 3, SES
e 0 [Reference] 0.48 (21.62–2.58) 0.73 (21.38–2.84) 0.501 60.0 53.5
Model 4, BMI+SES
f 0 [Reference] 0.30 (21.80–2.38) 0.41 (21.68–2.51) 0.700 75.8 73.9
Insulin, mU/L (n=4423)
Model 1, base
c 0 [Reference] 0.87 (0.12–1.62)
g 0.68 (20.07–1.43) 0.073 [Reference] [Reference]
Model 2, BMI
d 0 [Reference] 0.58 (20.11–1.27) 0.23 (20.46–0.93) 0.503 33.3 66.2
Model 3, SES
e 0 [Reference] 0.81 (0.06–1.57)
g 0.60 (20.16–1.36) 0.125 6.9 11.8
Model 4, BMI+SES
f 0 [Reference] 0.60 (20.10–1.29) 0.25 (20.46–0.95) 0.498 31.0 63.2
HOMA-IR (n=4423)
Model 1, base
c 0 [Reference] 0.28 (0.05–0.52)
g 0.23 (20.00–0.47) 0.052 [Reference] [Reference]
Model 2, BMI
d 0 [Reference] 0.20 (20.02–0.42) 0.10 (20.12–0.32) 0.352 28.6 56.5
Model 3, SES
e 0 [Reference] 0.24 (20.00–0.47) 0.17 (20.07–0.41) 0.159 14.3 26.1
Model 4, BMI+SES
f 0 [Reference] 0.17 (20.05–0.40) 0.07 (20.15–0.30) 0.536 39.3 69.6
BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); SES, socioeconomic status (including education, income and occupation).
aTertiles 1, 2 and 3 of African ancestry are ,80.3%, 80.3%–87.3% and .87.3%, respectively, for hemoglobin A1c,a n d,80.2%, 80.2%–87.3% and .87.3%, respectively,
for glucose, insulin, and HOMA-IR.
bEffects explained is defined as (b12b2)/b1 where b1 is the regression coefficient of traits in Model 1; b2 is the regression coefficient after adjustment for covariates in
each model.
cModel 1: Mean difference (95% confidence interval) is adjusted for age, sex, and study.
dModel 2: Mean difference (95% confidence interval) is adjusted for covariates in Model 1 and BMI.
eModel 3: Mean difference (95% confidence interval) is adjusted for covariates in Model 1 and SES.
fModel 4: Mean difference (95% confidence interval) is adjusted for covariates in Model 1, BMI, and SES.
gP,0.05, as compared to the reference tertile.
doi:10.1371/journal.pone.0032840.t003
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that in our study, markers of SES (education, income, and
occupation) account for only a modest proportion (,22%) of the
excess odds of type 2 diabetes due to ancestry. The results contrast
to previous findings in Hispanic Americans [26], where the
association between their non-European ancestry and type 2
diabetes is also significant, but where SES appears to be a much
greater confounder, as adjustment for it significantly attenuated
the association signal. It is also worth noting that the previous
study had less power than our study as it used fewer individuals
and fewer ancestry informative markers [26].
Insulin resistance and b–cell dysfunction are known to be major
factors in the pathogenesis of type 2 diabetes. Evidence from
epidemiological studies indicates that African Americans tend to
be more insulin resistant and have greater insulin responses to
glucose than European Americans [27–33]. Our results showed a
positive (but statistically non-significant) correlation between
African ancestry and HOMA-IR, in line with one earlier study
that demonstrated that children with greater African ancestry had
lower insulin sensitivity and a higher acute insulin response [34].
In genome-wide scans to date, the majority of the genetic variants
for type 2 diabetes identified in European-derived populations
appeared to be related to impaired insulin secretion [6,17,35],
while only IRS1 has been unequivocally associated with insulin
resistance [18]. However, a limitation is that these studies have
been carried out largely in Europeans. It will be interesting to
explore whether the loci associated to type 2 diabetes in African
Americans are also associated with impaired insulin secretion,
once genome-wide association studies of sufficient power are
carried out.
Previous genome-wide scans for type 2 diabetes in African-
descent populations have been extremely limited, and there has
only been one study using admixture-based approaches. In the
GENNID (Genetic of NIDDM) Study, using markers from a
linkage panel in 1,450 African Americans, the strongest admixture
association was found on chromosome 12 (90 cM), but no loci
achieved genome-wide significance [36]. In our large population
with a high number of ancestry informative markers, the two most
interestingly loci using were at 12p13.31 and 13q14.3. While
neither of these loci was significant by our locus-genome statistic
which has the most statistical power, the case-control Z score at
both loci exceeded the threshold for genome-wide significance,
which makes these loci of interest for further study. An attractive
candidate gene at the 12p13.31 locus is glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), which is a key enzyme in
the glycolytic pathway and is known to affect insulin receptor
signaling [37]. The 12p13.31 locus has been found to be associated
with type 1 diabetes in previous genome-wide association studies
in European-derived populations [15], but neither of the two loci
has been associated with type 2 diabetes in either African
Americans or Europeans.
An interesting feature of our admixture scanning results is that
diabetes risk at 12p13.31 and 13q14.3 were associated with
ancestry in opposite directions. At 13q14.3, greater European
ancestry is associated with a higher risk of diabetes, opposite to the
direction of the overall epidemiological association, a phenomenon
that we documented for the first time in a study of obesity loci
[38]. These two loci, together with the other modest admixture
signals on chromosome 12 and 1, and the absence of significant
signals in locus-genome statistic elsewhere in the genome, suggest
no evidence for a large genetic effect for type 2 diabetes that is
racially/ethnically differentiated, such as that at the MYH9/ApoL1
locus for non-diabetic end stage renal disease [22,39]. Thus
multiple loci modest effects may, in aggregate, explain the
apparent difference in genetic risk for type 2 diabetes between
African Americans and European Americans.
Our study has important limitations. Despite the fact that our
study size far exceeds previous genome scans for type 2 diabetes
risk loci in African Americans, statistical power remains an
important concern. We carried out simulation studies to examine
the power of our study to detect a genomic locus of elevated
African ancestry [40]. With a total of 2,373 diabetic cases, we
expect to have 80% power to detect a 1.8-fold increased risk of
type 2 diabetes per allele for alleles that are ancestry informative
between Europeans and West Africans but less power for weaker
ORs. A second limitation is that we used BMI as the only measure
of adiposity. Including some other measure, such as waist
circumference, might further attenuate the diabetes-ancestry
association. In our previous analysis, however, we found that
BMI, but not waist circumference, was significantly correlated
with genetic ancestry after adjustment for SES [41], suggesting
that confounding by waist circumference would have a minimal
effect on results. Third, as in many studies involving SES, we were
not able to fully assess SES and made inferences about SES based
on education, income, and occupation, which, although are strong
markers for SES, are still imperfect [42]. For example, SES may
also be correlated with other diabetes risk factors, such as diet and
life-style, and historical socioeconomic factors could in theory
Figure 2. Admixture scans for genetic loci of type 2 diabetes in African Americans. Locus-genome statistic (LOD score, red line) and case-
control statistic (Z score, blue gray line) are shown. A signal was detected at 12p13.31 with a locus-specific LOD score of 4.0, just reaching the
threshold of 4 for suggestiveness. The 12p13.31 peak was also supported by the case-control statistic (Z score=24.2, nominal P=3.3610
25). The
second strongest admixture signal was observed on the same chromosome at 12q13.13 (locus-specific LOD=3.8). There was also an admixture peak
at 13q14.3 that did not reach genome-wide significance by the locus-genome statistic (locus-specific LOD=1.1), but that had the largest magnitude
case-control Z score anywhere in the genome (Z score=4.5, nominal P=6.6610
26).
doi:10.1371/journal.pone.0032840.g002
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diabetes risk, making the associations among them even more
complicated.
In summary, in community-based populations with more than
7,000 African Americans, we found that genetic ancestry is
significant associated with type 2 diabetes above and beyond the
effects of markers of SES, and we detected several suggestive loci
that may harbor genetic variants modulating diabetes risk. These
results suggest that in African Americans, genetic ancestry has a
significant effect on the risk of type 2 diabetes that are independent
of the contribution of SES, but that no single locus with a major
effect explains a large portion of the observed disparity in diabetes
risk between African Americans and European Americans. In
addition, they suggest that genetic measured African ancestry
contributes to the risk of type 2 diabetes via both genetic and non-
genetic pathways. The effect of ancestry on any individual locus in
the genome is likely to be modest, but in aggregate, differences in
ancestry may contribute substantially to the observed ethnic
disparity in risk of type 2 diabetes.
Materials and Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. All data collections were carried out
according to protocols approved by Johns Hopkins Bloomberg
School of Public Health Institutional Review Board for the study
of human subjects. Written informed consent was obtained from
all participants.
Study populations
The individuals enrolled in the present study came from three
studies: the ARIC, JHS and MEC studies (Table 1). A detailed
description of the three studies as well as the numbers of
participants that were analyzed after applying various data quality
filters are presented in Text S1. A brief description of each study is
provided here.
The ARIC study is a prospective epidemiologic study that
examines clinical and subclinical atherosclerotic disease in a
cohort of 15,792 persons, including 4,266 self-reported African
Americans, aged 45 to 64 years at their baseline examination from
1987 to 1989. The sampling procedure and methods used in
ARIC have been described in detail elsewhere [43]. A total of
2,285 African-American participants from the ARIC study were
included in the current analysis.
The JHS is a long-term, community-based observational study
of cardiovascular disease and its risk factors in 5,301 self-identified
African Americans recruited between 2000 and 2004 from three
counties surrounding Jackson, Mississippi [44,45]. Unrelated
persons aged 35–84 were enrolled, and the remaining participants,
at least 21 years old, were members of the nested JHS Family
Study [46]. A total of 3,185 participants from the JHS were
included in the current study.
The MEC study is a prospective cohort of 215,251 individuals
recruited between 1993 and 1996 in Hawaii and Los Angeles,
California, of whom 16.3% were African Americans [47].
Potential cohort members were identified primarily through
Department of Motor Vehicles drivers’ license files and,
additionally for African Americans, Health Care Financing
Administration data files. Participants were between the ages of
45 and 75 years at the time of recruitment. A total of 1,551
African-American participants from the MEC study, selected for a
diabetes case-control study, were included in this analysis.
Diabetes and related traits
Information on body weight and height was collected in all
three studies. In ARIC and JHS, anthropometry was performed
during the clinical visit in the fasting state with an empty bladder
by certified technicians. Body mass index was calculated as weight
(in kg)/height (in meters) squared. In MEC, BMI was calculated
using self-reported weight and height. The ARIC Study and JHS
also have measurements of other diabetes-related quantitative
traits, including fasting serum glucose and insulin concentrations,
and HbA1c. Participants were asked to fast for at least 12 hours
before morning blood collection. Blood samples were collected
into vacuum tubes containing serum-separator gel (glucose,
insulin) or EDTA (HbA1c). Specimens were then processed and
analyzed in the ARIC and JHS Central Laboratories at University
of Minnesota [48,49]. Serum glucose and insulin were measured
by the hexokinase method [49,50] and by radioimmunoassay [49],
respectively. HbA1c was assayed with Tosoh HPLC instruments
[48,49]. The present analysis used data from the baseline
examination in all three cohorts, except that in ARIC HbA1c
was measured in stored whole blood samples from the second
clinical visit [48]. Insulin resistance was estimated by the
homeostasis model assessment (HOMA-IR) as fasting plasma
glucose [mmol/l] times fasting serum insulin [mU/L] divided by
22.5.
Type 2 diabetes was defined as the presence of any one of the
following at the baseline examination in the ARIC and JHS
studies: 1) fasting glucose $7.0 mmol/l (126 mg/dl); 2) non-
fasting glucose $11.1 mmol/l (200 mg/dl); 3) hemoglobin A1c
$6.5% [51]; 4) current use of diabetic medication; or 5) a positive
response to the question ‘‘Has a doctor ever told you that you had
diabetes (sugar in the blood)?’’ In addition, diabetic individuals in
ARIC or JHS who reported age of diagnosis younger than 30
years were excluded. In the MEC, diabetic individuals were
defined as those who indicated on the baseline or follow-up
questionnaires that they had a history of diabetes, and were taking
medication for diabetes at the time of blood draw. The question
did not differentiate between type 1 diabetes and type 2 diabetes,
and thus we expect a small fraction (,10%) of the respondents to
have type 1 diabetes [52]. In the ARIC and JHS study, non-
diabetic controls were defined as African-American participants
who did not have diabetes and were derived from the same
populations as the diabetic cases. In the MEC, non-diabetic
controls were from a group of samples who neither had a history of
diabetes nor were taking medication for diabetes and had been
specifically genotyped as part of previous admixture scans for
prostate cancer [20] and hypertension [53].
Socioeconomic status
Information on three SES indicators, including personal
education level, occupation, and family income, was collected
during the baseline interview in the ARIC and JHS study. For the
purpose of this analysis, education level was categorized into four
groups: 1) less than high school; 2) high school graduate or high
school-level General Educational Development credential; 3) some
college; or 4) college completed, or some graduate or professional
school. Income level was categorized as affluent, upper-middle,
lower-middle, or poor based on total combined family income,
family size, and poverty levels in each year when the interview was
conducted. Some participants (9.5% and 13.8% in ARIC and
JHS, respectively) did not provide their income information and
were coded as a separate category (missing). A more detailed
description of the assessment of income is presented in Text S1.
Occupations were categorized according to the criteria of the 1980
U.S. census into six groups: managerial and professional specialty;
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forestry and fishing or precision production; operators, fabricators,
laborers or construction; and homemakers [54]. Because cohort
controls had not been genotyped in the MEC (as we had
oversampled particular phenotypes for genetic studies), the
analyses of SES was limited to ARIC and JHS only.
Genotyping
Participants were genotyped with at least one of three iteratively
improved and partially overlapping panels of ancestry-informative
SNP markers [23,25,41,55,56]. The ARIC study used the Phase 3
panel, the JHS study used Phase 2 and 3, and the MEC study used
all three panels. Altogether 2,189 markers were genotyped in the
present study, with a median of 1,243 markers per individual. We
used previously published genotyping data to estimate the
frequency of each SNP in West Africans and European
Americans, the two parental populations of African Americans
[20,53,55]. A series of filters, as described previously [25,55–57],
were applied to detect and remove SNPs with problematic
genotyping. Genotyping details, estimates of allele frequencies,
and SNP quality control checks are presented in Text S1.
Estimating genetic ancestry
We estimated each subject’s global percentage of African
ancestry using the ANCESTRYMAP software [40]. ANCES-
TRYMAP uses a Hidden Markov Model (HMM) to combine the
weak information about local ancestry that is provided by each
SNP into a more confident estimate that incorporates information
from many neighboring markers. Use of the HMM to estimate
genetic ancestry is described in more detail in Text S1.
Statistical analysis
Statistical analyses were performed using Stata 10.1 (Stata
Corporation, College Station, Texas, US) and ANCESTRYMAP.
Initial analyses of the correlation between African ancestry and
either SES or the diabetes-related quantitative traits were
performed using Spearman’s correlation coefficient (r). Analyses
of ancestry associations were conducted using pooled data from all
three cohorts. Quantitative traits were available for analysis in
ARIC and JHS only.
We used logistic regression models to estimate the OR for
diabetes, comparing tertiles 2 and 3 to the lowest tertile of the
distribution of African ancestry. To explore further potential
nonlinear ancestry-diabetes associations, we used restricted cubic
splines with equally-spaced knots at the 5th, 35th, 65th, and 95th
percentiles of the ancestry distribution. For quantitative traits, we
used linear regression models to determine the proportion of
variation in trait levels explained by each variable (i.e., the
coefficient of determination) and to assess the change in trait levels
with ancestry tertiles. We constructed a series of multivariate
models for our regression analyses. The base models were adjusted
for age, sex and study only. Subsequent models were created by
introducing BMI and SES as covariates, separately and collectively
in sequence, because both SES and BMI correlate with ancestry
[38,41] and thus may potentially confound ancestry-diabetes
association.
To quantify the extent to which groups of covariates appeared
to explain the excess odds of diabetes with increasing African
ancestry, we calculated the percentage reduction in the OR
associated with adjustment (see Text S1 for more details). Similar
calculation was performed to determine the relative contribution
of covariates to the observed association between ancestry and
quantitative traits.
We used ANCESTRYMAP [40] to search for genomic regions
associated with an increased percentage of either European or
African ancestry. The ANCESTRYMAP software provided two
statistics: a locus-genome statistic and a case-control statistic.Alocus-
genome statistic was obtained in cases by calculating the likelihood of
the genotyping data at the SNPs at the locus under a risk model
and comparing it to the likelihood of the genotyping data at the
SNPs at the locus assuming that the locus is unassociated with the
phenotype [40]. We tested 6 pre-specified European ancestry risk
models ranging from 0.7 to 1.3. To accumulate evidence of
association in these models, we averaged the ratio of these two
likelihoods emerging from each model at each point in the
genome, taking the log10 of this likelihood ratio to produce a locus-
specific LOD score. We considered a locus-specific LOD score for
association at a particular locus of .5 as genome-wide significant
and .4 as suggestive [58]. To obtain an assessment of the
evidence for a risk locus anywhere in the genome, we averaged the
likelihood ratio for association across all loci in the genome, and
took the log10 to obtain a ‘‘genome-wide score’’ [58]. We
interpreted a genome-wide score .2 as significant, and .1a s
suggestive.
A case-control statistic was calculated by comparing locus-specific
deviations in European ancestry in cases versus controls at each
locus across the genome [40]. For loci identified by the case-
control statistic, the level of genome-wide significance was defined
as a Z score .4.06 or ,24.06, corresponding to an uncorrected
nominal P,5610
25, or a corrected nominal P,0.05 after
conservatively correcting for 1,000 hypotheses tested (approxi-
mately equals the number of independent chromosomal segments
assigned to either African or European ancestry).
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